EP3055288
ANTIDIABETIC TRICYCLIC COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.9.2014EP published:
16.12.2020EP application number:
14852689.0
EPO information:
European Patent Register
Max expiry date:
29.9.2034
Title:
ANTIDIABETIC TRICYCLIC COMPOUNDS
Timeline
Today
30.9.2014EP application
16.12.2020EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, Rahway, NJ 07065, US
Inventor
Name:
BIFTU, TesfayeAddress:
Rahway, New Jersey 07065-0907, US
Name:
BIJU, PurakkatleAddress:
Kenilworth, New Jersey 07033, US
Name:
COLLETTI, Steven L.Address:
Kenilworth, New Jersey 07033, US
Name:
CUI, MingxiangAddress:
Shanghai 200131, CN
Name:
HAGMANN, William K.Address:
Westfield, New Jersey 07090, US
Name:
HU, BinAddress:
Shanghai 200131, CN
Name:
JOSIEN, HubertAddress:
Kenilworth, New Jersey 07033, US
Name:
KAR, Nam FungAddress:
Brooklyn, New York 11204, US
Name:
NAIR, AnilkumarAddress:
Kenilworth, New Jersey 07033, US
Name:
NARGUND, RaviAddress:
Kenilworth, New Jersey 07033, US
Name:
SPERBECK, Donald M.Address:
Kenilworth, New Jersey 07033, US
Name:
ZHU, ChenAddress:
Kenilworth, New Jersey 07033, US
Priority
Number:
PCT/CN2013/084846Date:
8.10.2013Country:
WO
Classification
Categories:
C07D 221/16, C07D 401/12, C07D 405/12, A61K 31/444, A61K 31/435, A61P 3/10